enGene Therapeutics Inc.

enGene Therapeutics Inc. financial statements

enGene Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 117.3M10-K
Cash and equivalentsUSD 50.15M10-Q

enGene Therapeutics Inc. financials on 6ix · enGene Therapeutics Inc. on 6ix